C. Shih

发表

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users

S. Chuah, P. Hsu, Chang‐Bih Shie, 2022, Medicina.

Gallbladder function predicts subsequent biliary complications in patients with common bile duct stones after endoscopic treatment?

Huey-Shyan Lin, P. Hsu, Sung‐Shuo Kao, 2018, BMC Gastroenterology.

Inhibition of 8-hydroxydeoxyguanosine formation by curcumin in mouse fibroblast cells.

J K Lin, C A Shih, C. Shih, 1993, Carcinogenesis.

Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy

Wen-Chi Chen, C. Shih, 2021, World journal of clinical cases.

Risk factors of incomplete response to proton pump inhibitor therapy in patients with mild erosive esophagitis

Deng-Chyang Wu, S. Chuah, C. Kuo, 2015 .

Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis

Hui‐Chun Chen, P. Hsu, K. Lai, 2015, PloS one.

Update on the first-line treatment of Helicobacter pylori infection in areas with high and low clarithromycin resistances

P. Hsu, Chang‐Bih Shie, C. Shih, 2022, Therapeutic advances in gastroenterology.

Ten‐Day Quadruple Therapy Comprising Proton‐Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin Achieves a High Eradication Rate for Helicobacter pylori Infection after Failure of Sequential Therapy

Deng-Chyang Wu, H. Tseng, Angela Chen, 2014, Helicobacter.

Pseudomelanosis duodeni in a female adult with chronic renal failure

P. Hsu, K. Lai, F. Tsay, 2014 .

REAP‐HP survey 2020: Comparing the real‐world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020

Deng-Chyang Wu, S. Chuah, P. Hsu, 2022, Helicobacter.

Update on the second-line treatment of Helicobacter pylori infection: a narrative review

S. Chuah, P. Hsu, W. Tai, 2023, Therapeutic advances in gastroenterology.